Pfizer has been a big name in healthcare for decades, but it has been a largely underwhelming investment over the past 10 ...

If RFK has his way, even if you still have coverage, you may not be able to afford the shots that your doctor wants to give.

A political firestorm has erupted in Brussels as French MEPs accuse European Commission President Ursula von der Leyen of secretly negotiating a €35 billion vaccine deal with Pfizer—via SMS. With no ...

Pfizer recently announced positive results from the BASIS study, the global phase 3 trial evaluating Hympavzi in young adults ...

BRUSSELS (CNS) — European Commission President Ursula von der Leyen defended herself before the European Parliament Monday as ...

Despite representing only 4% of the world's population, the United States accounts for over half of science Nobel Prizes ...

Ashwin Kishtagari, MD, of Vanderbilt University Medical Center in Nashville, summarizes 7 studies presented at the EHA 2025 Congress.

Gabriella Ngang, of Farmington Hills, is one of three in Michigan to take part in a clinical trial of a new sickle cell ...

The new memos from the Food and Drug Administration show how the agency’s vaccine chief, Dr. Vinay Prasad, personally ...

Wall Street's smartest money has quietly amassed over $150 million in bullish positions, with Goldman Sachs eliminating all ...

Robert "Bob" Cooper of the L.A. firm Gibson Dunn defended some of the country’s largest and most recognizable companies from ...

I didn’t set out to build a global innovation network spanning 45 countries. Here are four lessons from my journey.